
|Articles|February 11, 2008
FDA's crackdown on bio-identical hormones sparks controversy
Pharmacists are up in arms over the warning FDA has issued to seven compounding pharmacies about bioidentical hormone replacement therapy.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Vaccination of 3 Or More Doses Reduces Incidence of COVID-19 Symptoms for Young Adults
2
CVS Pharmacy Acquires Select Rite Aid Assets in 3 States, Accounting for Over 600 Stores
3
FDA Approves Afibercept-Boav as Biosimilar to Afibercept for Diabetic Macular Edema
4
Introduction of PCV10 Reduces Pneumococcal Infections for Children
5